Swisse Lecithin supports liver Health & function. Lecithin is a source of phospholipids, important for the health and structure of cell membranes.
Benefits:
Swisse Ultiboost Lecithin is a premium quality formula to support liver health and fat metabolism.
Liver Health: The liver is responsible for eliminating toxins, aiding digestion and helping regulate metabolism. Lecithin contains choline, which supports liver function and helps maintain a healthy liver.
Fat Metabolism: The choline in lecithin contributes to normal fat metabolism. Source of Phospholipids: Lecithin is a source of phospholipids, important for the health and structure of cell membranes.
General Wellbeing: Assists in the maintenance of general health and wellbeing. Derived from Soybeans: Naturally sourced from soybeans.
Derived from Soybeans: Assists in the maintenance of general health and wellbeing.
Swisse Ultiboost Lecithin has been formulated based on scientific evidence to help support a healthy liver.
Active Ingredients
Lecithin 1.2g
** No added gluten, lactose, egg, yeast, preservatives and artificial flavours.
Directions For Use
Five Capsules daily or as directed by a healthcare professional.
Place of origin
Australia
Best date before 2026-02-28
Warning
Always read the label.
Use only as directed.
If symptoms persist, see your healthcare practitioner.
This product is not registered under the "Pharmacy and Poisons Ordinance" or the "Chinese Medicine Ordinance". Any claim made for it has not been subject to evaluation for such registration. This product is not intended to diagnose, treat or prevent any disease.
About Swisse
Swisse is an Australian success story. It all began with founder Kevin Ring in a humble Melbourne warehouse in 1969. From the outset, our mission was embedded in the Swisse DNA – a dream to make people all over the world healthier and happier. Today, the Swisse product range stretches from top selling men’s and women’s multivitamins and dietary supplements, to sports nutrition, skincare and functional foods. Swisse products are currently available in Australia, New Zealand, China, Singapore, the UK, Italy and the Netherlands, with plans to launch in up to 30 countries in the next five years.
